Male Breast Cancer Completed Phase 1 / 2 Trials for Tipifarnib (DB04960)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00470301Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerTreatment